3 recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow T Cells: new trials by email Literature Review of T Cells trials Research Report on T Cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus Evaluation of cellular response - Hepatitis B Vaccination, Immune Response | Recruiting | Assistance Publique - Hôpitaux de Paris | 115 | 2025-08-11 | 2026-04-23 | |
| Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer? Low intensity exercise, High intensity exercise - Oesophageal Adenocarcinoma, T Cells | Not applicable | Recruiting | University of Surrey | 50 | 2024-04-26 | 2026-02-02 |
| A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome Naproxen, Aspirin - T Cells, Colorectal Cancer | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2023-03-21 | 2026-06-01 |
Adenocarcinoma Of Esophagus (1) · Colorectal Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Esophageal Neoplasms (1) · Motor Activity (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Behavior (1) · Colonic Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Repair-Deficiency Disorders (1) · Esophageal Diseases (1) · Genetic Diseases, Inborn (1) · Head and Neck Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1)
Aspirin (1) · High-Intensity Interval Training (1) · Naproxen (1)
Assistance Publique - Hôpitaux de Paris (1) · M.D. Anderson Cancer Center (1) · University of Surrey (1)
France (1) · United Kingdom (1) · United States (1)
Adam Frampton, PhD (1) · Eduardo Vilar-Sanchez, MD (1)
R01CA257375 (1)